Cargando…
Therapeutic Treatment Approaches Post–Myocardial Infarction: A Bias Toward Formyl Peptide Receptor Agonists
FIRST AUTHOR: [Figure: see text] CORRESPONDING AUTHOR: [Figure: see text]
Autores principales: | Zaman, Rysa, Epelman, Slava |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6938984/ https://www.ncbi.nlm.nih.gov/pubmed/31909772 http://dx.doi.org/10.1016/j.jacbts.2019.11.008 |
Ejemplares similares
-
Using High-Dimensional Approaches to Probe Monocytes and Macrophages in Cardiovascular Disease
por: Dick, Sarah A., et al.
Publicado: (2019) -
Cardiac Macrophages, Reactive Oxygen Species, and Development of Left Ventricular Dysfunction
por: Wang, Yiming, et al.
Publicado: (2017) -
Preservation of Post-Infarction Cardiac Structure and Function via Long-Term Oral Formyl Peptide Receptor Agonist Treatment
por: García, Ricardo A., et al.
Publicado: (2019) -
Small-molecule-biased formyl peptide receptor agonist compound 17b protects against myocardial ischaemia-reperfusion injury in mice
por: Qin, Cheng Xue, et al.
Publicado: (2017) -
Differential activation of polymorphisms of the formyl peptide receptor by formyl peptides
por: Mills, John S.
Publicado: (2007)